Results 81 to 90 of about 16,889 (275)

Psychotropic Medications-Induced Tardive Dyskinesia and Associated Factors Among Patients with Mental Illness in Ethiopia

Clinical Pharmacology: Advances and Applications, 2020
Assefa Kumsa, Shimelis Girma, Bezaye Alemu, Liyew Agenagnew Department of Psychiatry, Faculty of Medical Science, Institute of Health, Jimma University, Jimma, EthiopiaCorrespondence: Liyew AgenagnewJimma University, 378, Jimma, EthiopiaTel +251 ...
Kumsa A, Girma S, Alemu B, Agenagnew L
doaj  

Role of Serotonin Neurons in L-DOPA- and Graft-Induced Dyskinesia in a Rat Model of Parkinson's Disease

Parkinson's Disease, 2012
L-DOPA, the most effective drug to treat motor symptoms of Parkinson's disease, causes abnormal involuntary movements, limiting its use in advanced stages of the disease.
Eunju Shin, Elisabetta Tronci, Manolo Carta   +2 more
doaj   +1 more source

Dyskinesia induced by phenytoin Discinesia induzida por fenitoína

Arquivos de Neuro-Psiquiatria, 1999
Phenytoin is an effective antiepileptic drug, although, it can be associated with many side effects, including dyskinesia. OBJECTIVE: To describe the clinical characteristics of phenytoin induced dyskinesia.
M. AUGUSTA MONTENEGRO, ANNA ELISA SCOTONI, FERNANDO CENDES   +2 more
doaj   +1 more source

Ziconotide-Induced Oro-lingual Dyskinesia: 3 Cases.

, 2020
BACKGROUND: Ziconotide (ZCN), a nonopioid analgesic, is first-line intrathecal therapy for patients with severe chronic pain refractory to other management options. We describe three cases of ZCN-induced movement disorders.
Azher, Sharmeen, Gupta, Megan, Grajny, Kristopher, MD, Adam, Octavian, Durphy, Jennifer, Molho, Eric   +5 more
core  

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source

Deep Brain Stimulation of Caudal Zona Incerta for Parkinson's Disease: One‐Year Follow‐Up and Electric Field Simulations

Neuromodulation: Technology at the Neural Interface, EarlyView., 2021
Abstract Objective To evaluate the effects of bilateral caudal zona incerta (cZi) deep brain stimulation (DBS) for Parkinson's disease (PD) one year after surgery and to create anatomical improvement maps based on patient‐specific simulation of the electric field.
Rasmus Stenmark Persson, Teresa Nordin, Gun‐Marie Hariz, Karin Wårdell, Lars Forsgren, Marwan Hariz, Patric Blomstedt   +6 more
wiley   +1 more source

Randomized clinical trial of topiramate for levodopa-induced dyskinesia in Parkinson's disease

, 2014
BACKGROUND: The antiepileptic drug topiramate reduces levodopa-induced dyskinesia without exacerbating parkinsonism in animal models. We report a randomized, double-blind, placebo-controlled crossover trial in patients with Parkinson's disease and ...
Kobylecki, Christopher; id_orcid, Kellett, Mark W, Silverdale, Monty A, Kass-Iliyya, Lewis, Burn, David J, Crossman, Alan R   +5 more
core   +1 more source

The Spectrum of Abnormal Tongue Movements: Review of Phenomenology, Etiology, and Differential Diagnosis

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Classifying abnormal tongue movements is challenging due to their varied presentations and limited visibility compared to other body parts. Accurate identification of the phenomenology guides physical examination and can point to specific diagnoses.
Nathaniel Bendahan, Seyed‐Mohammad Fereshtehnejad, Christos Ganos, Emily Swinkin, Anthony E. Lang   +4 more
wiley   +1 more source

Canine paroxysmal dyskinesia—a review

Frontiers in Veterinary Science
Paroxysmal dyskinesias (PDs) are a group of involuntary, hyperkinetic movement disorders that recur episodically and may last seconds to hours. An important feature of PD is that there is no loss of consciousness during the episode.
Paul J. J. Mandigers, Paul J. J. Mandigers, Koen M. Santifort, Koen M. Santifort, Koen M. Santifort, Mark Lowrie, Laurent Garosi   +6 more
doaj   +1 more source

Drug-induced tardive dyskinesia: A case report

European Psychiatry, 2016
IntroductionTardive dyskinesia (TD) is a serious medical condition that affects a significant proportion of patients treated with antipsychotic agents.ObjectiveTo report a patient who developed tardive dyskinesia after initiation of antipsychotic and antidepressant treatment.Case reportMiss H.
I. Abida, I. Baati, S. Omri, R. Sallemi, J. Masmoudi   +4 more
openaire   +1 more source